The strengths and limits of such approaches differ in accordance with the substance researched and for the several techniques utilised inside of these two approaches, which might be reviewed in a track record paper commissioned for this report (Udrisard et al., 2022). Other methods and novel methods also exist to estimate drug industry dimensions,